Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer.

Saved in:
Bibliographic Details
Title: Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer.
Authors: Sambe T; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Imamura CK; Advanced Cancer Translational Research Institute, Showa Medical University, 8-5-1 Hatanodai, Shinagawa-ku, 142-8555, Tokyo, Japan. imamurack@med.showa-u.ac.jp., Hida N; Division of Clinical Research and Development, Department of Clinical Pharmacy, Showa Medical University School of Pharmacy, Tokyo, Japan., Yamazaki T; Division of Clinical Research and Development, Department of Clinical Pharmacy, Showa Medical University School of Pharmacy, Tokyo, Japan., Mizukami T; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan., Ryu K; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Fukunaga K; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Mushiroda T; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Miyakawa H; Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Saga, Japan., Uchiyama S; Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Saga, Japan., Uchida N; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Dec 08; Vol. 95 (1), pp. 123. Date of Electronic Publication: 2025 Dec 08.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0843
DOI:10.1007/s00280-025-04852-y